Holen Sie sich die Stockscreener-App
15.68
3.57%
0.54
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AUPH?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$15.14
Offen:
$15.12
24-Stunden-Volumen:
1.28M
Relative Volume:
0.77
Marktkapitalisierung:
$2.07B
Einnahmen:
$260.11M
Nettoeinkommen (Verlust:
$60.64M
KGV:
36.47
EPS:
0.43
Netto-Cashflow:
$92.29M
1W Leistung:
+2.15%
1M Leistung:
+32.43%
6M Leistung:
+88.01%
1J Leistung:
+78.79%
1-Tages-Spanne:
$14.94
$15.75
1-Wochen-Bereich:
$14.94
$15.81
52-Wochen-Spanne:
$6.55
$16.20
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
Firmenname
Aurinia Pharmaceuticals Inc
Sektor
Branche
Telefon
250-744-2487
Adresse
#140, 14315 - 118 AVENUE, EDMONTON, BC
Vergleichen Sie AUPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
15.68 | 2.00B | 260.11M | 60.64M | 92.29M | 0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Hochstufung | Jefferies | Hold → Buy |
| 2025-11-05 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-07-30 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-11-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-05-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-10-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-01-25 | Bestätigt | H.C. Wainwright | Buy |
| 2020-11-03 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-17 | Eingeleitet | BTIG Research | Buy |
| 2020-05-05 | Eingeleitet | Cowen | Outperform |
| 2020-01-10 | Eingeleitet | Jefferies | Buy |
| 2019-12-16 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-16 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-02-08 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-18 | Bestätigt | H.C. Wainwright | Buy |
| 2017-04-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-22 | Bestätigt | FBR & Co. | Outperform |
| 2016-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-17 | Bestätigt | H.C. Wainwright | Buy |
| 2016-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-05-08 | Eingeleitet | MLV & Co | Buy |
Alle ansehen
Aurinia Pharmaceuticals Inc Aktie (AUPH) Neueste Nachrichten
Is Aurinia Pharmaceuticals Inc. stock positioned for long term growthWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Aurinia Delivers Growth While Balancing Biotech Risks - Finimize
Is Aurinia Pharmaceuticals Inc. stock a good choice for value investorsTrade Volume Report & Low Risk Growth Stock Ideas - newser.com
Will Aurinia Pharmaceuticals Inc. stock deliver consistent dividends2025 Geopolitical Influence & Expert-Curated Trade Recommendations - newser.com
Will Aurinia Pharmaceuticals Inc. (IKAP) stock return to pre crash levelsEarnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com
Will Aurinia Pharmaceuticals Inc. stock see PE expansionJuly 2025 Market Mood & Proven Capital Preservation Methods - newser.com
Is Aurinia Pharmaceuticals Inc. stock positioned for digital transformationJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - newser.com
Will Aurinia Pharmaceuticals Inc. (IKAP) stock rise with strong economyTrade Volume Report & Low Risk Growth Stock Ideas - newser.com
How Aurinia Pharmaceuticals Inc. (IKAP) stock correlates with oil marketsJuly 2025 Pullbacks & Weekly Top Gainers Alerts - newser.com
Chart overlay techniques for tracking Aurinia Pharmaceuticals Inc.2025 Trading Volume Trends & Growth-Oriented Investment Plans - newser.com
What earnings margins imply for Aurinia Pharmaceuticals Inc. (IKAP) stockWeekly Trade Report & Low Risk Investment Opportunities - newser.com
Can Aurinia Pharmaceuticals Inc. (IKAP) stock surprise with quarterly results2025 Biggest Moves & Smart Money Movement Tracker - newser.com
Is Aurinia Pharmaceuticals Inc. stock positioned well for digital economyMarket Weekly Review & AI Powered Buy/Sell Recommendations - newser.com
Visualizing Aurinia Pharmaceuticals Inc. stock with heatmaps2025 Technical Overview & Free Weekly Watchlist of Top Performers - newser.com
Finanzdaten der Aurinia Pharmaceuticals Inc-Aktie (AUPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):